Biopharmaceutical Supplier Risk Management: What You Need to Know Now

By |2021-10-13T11:12:51-04:0010/13/2021|

The COVID-19 pandemic exposed the risks and fragility inherent in global pharmaceutical and biotechnology supply chains. This isn’t really news though. For some time, these supply chains have lagged other industries in speed, flexibility, agility, redundancy, and diversification. With risk considerations at the forefront resulting from shortages during the pandemic, the US government is [...]

Global Trade Compliance: Why Emerging Biopharmaceutical Company Operations Executives Need to Take Notice

By |2021-09-30T13:18:28-04:0009/27/2021|

Today’s biopharmaceutical supply chains often stretch around the world. Key starting materials (KSM) and API originate more frequently from Asia. Manufacturing is commonly conducted in Europe and North America. And commercial distribution is spread across the globe. This globalization has resulted in increased logistics and global trade compliance (GTC) complexity along with ever-changing import/export [...]

Event Recap: Why is Now the Time for Digital Supply Chain Transformation

By |2021-09-14T11:02:07-04:0009/14/2021|

Clinical supply professionals are responsible for ensuring that patients on clinical trials receive the right drug at the right time for their treatment protocols. The environment is dynamic and challenging, so companies embrace innovation to enable educated and responsible supply decision making. More than ever, biopharmaceutical sponsors are moving towards a digital clinical supply [...]

5 Unique Logistics Challenges for Specialty Pharmaceuticals

By |2021-07-29T10:15:32-04:0007/28/2021|

Many of our clients are innovator companies developing novel treatments that are often complex and extremely high value. As a result, they face similar supply chain challenges in preparing for commercialization. Often, these specialty products are also orphan and rare disease treatments, as well as extremely low volume. The supply chains for these emerging [...]

Building Supply Chain Resilience: The Biden Administration’s 100-Day Supply Chain Review Findings on Pharmaceuticals and APIs

By |2021-06-24T11:32:22-04:0006/24/2021|

On February 24, 2021, President Biden signed an Executive Order on America’s Supply Chains (EO) as a step toward building more secure, robust and resilient supply chains. The EO initiated a 100-Day Supply Chain Review, which detailed an assessment of the strengths and weaknesses of the domestic supply chains for four key product areas, one of which included a review of pharmaceuticals and [...]

The CARES Act & Your Supply Chain: What You Need to Know

By |2021-06-24T11:34:46-04:0006/24/2021|

Jeremy Friedler, senior consultant, and Rashi Gupta, consultant, focus on biotechnology and pharmaceutical operations at Converge Consulting. The COVID-19 pandemic and resulting economic crisis exposed the vulnerabilities of both domestic and global supply chains across multiple industries. Given the complexity and far-reaching global nature of their supply chains, pharmaceutical and biotechnology companies were [...]

Event Recap: Global Logistics & Trade in a Post-Pandemic World

By |2021-05-18T10:58:20-04:0005/18/2021|

The current pandemic is severely impacting life science supply chains. There are supply delays, constrained transportation and cold storage, and reduced demand. As the pandemic begins to ease in some parts of the world, Supply Chain leaders are preparing for the post-pandemic global logistics and trade environment. Our Life Sciences Supply Chain Working Group (SCWG) [...]

Thinking Differently about Safety Stock

By |2021-04-13T11:37:36-04:0004/13/2021|

Inventory comes in many shapes and sizes, quite literally, but for life sciences one thing is certain: effectively managing inventory is a make-or-break moment for delivering patient-centric care. I have seen this value potential play out while working with dozens of emerging companies to build efficient inventory management strategies. Many senior leaders underestimate how [...]

Benefits of Early Launch Planning

By |2021-03-18T14:03:38-04:0003/03/2021|

Preparing for commercial launch is a complex process for most any life science company. Adding to the challenge, many emerging life sciences companies operate as very lean organizations with limited resources. Specialty products in particular can be one-of-a-kind and require unique launch processes and procedures. In some cases, team members are also doing it [...]

Building Agility into the Clinical Supply Chain

By |2021-02-10T19:17:56-05:0002/09/2021|

There are incredibly innovative trends taking place in clinical supply right now. Clinical trials are being "brought to life" from synopsis to final protocol to FPI in a few weeks. Direct-to-patient shipments and remote patient monitoring are becoming essential practices for dealing with difficult situations. There continues to be inherent risk and uncertainty in [...]

Go to Top